Company intelligence / Profile preview

Volition Veterinary

Austin, Texas, USA

Ownership: Private
Development stage: Other

Overview

Commercialized Nu.Q Vet Cancer Test detects 74% of lymphoma and 89% of hemangiosarcoma at 100% specificity; ongoing clinical study for feline lymphoma detection with results expected 2026

Therapeutic areas: Oncology
Industry: Veterinary

Partnerships

Texas A&M University GI Lab (distribution)Werfen (human licensing, related platform)Hologic (human co-marketing, related platform)

Beyond the preview

Go deeper on Volition Veterinary.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Volition Veterinary.

Explore the full profile